Nation of SettlersImmigration Policy Research

Data · Public Health

How Many Vaccines? A Country-by-Country Comparison

Wealthy countries protect their children against the same diseases, but they do not use the same schedule. The United States gives one of the most extensive. Several countries deliberately give less. This is a comparison of those choices, and of what the evidence says about them.

A note on what this is and is not. Every health authority cited here accepts these vaccines as safe and effective. The differences below are about strategy, timing, whom to target, and cost, not about safety. Where the evidence is settled, this page says so; where reasonable experts disagree, it says that too.
3,041 → 126
antigens (the germ pieces the immune system reacts to) in the schedule, 1980 vs 2000 - a lighter load, despite more shots
up to 24
injections by age 2 on the US schedule, up to 5 in one visit
11
infant vaccines France legally mandates; most of Europe mandates none
83 vs 78
years of life expectancy: Japan, Korea, and Australia all outlive the US, and all vaccinate extensively

How many, and when

Toggle between the timeline (how many shots a baby gets at each visit) and the vaccine list (doses by age 2). The timeline is the view that matters for the delayed-schedule question: it shows how early and how heavily the shots are clustered.

The baby's age runs down the side; each cell is the number of injections - needles - at that visit. Hover the info icon to see which vaccines. A combination shot, like the 6-in-1, is a single needle that covers several vaccines at once, so a low number can still deliver many vaccines. The US number runs higher mostly because it uses fewer combination shots, not because it protects against more diseases.

Baby's age
🇺🇸
US
🇬🇧
UK
🇫🇷
France
🇩🇪
Germany
🇩🇰
Denmark
🇸🇪
Sweden
🇦🇺
Australia
Birth1
1
2 months5
2
2
3
2
3 months1
1
2
2
4 months4
3
2
3
2
5 months1
2
2
6 months6
1
1
11 months2
4
12 months5
3
3
1
2
2
3
15-18 months2
2
1
1
1
1
3
Injections by age 2231113127712

Timeline cells are the injections given at each visit, derived from each national schedule; the US assumes separate shots and is fewer where a clinic uses combination products. The vaccine view shows doses by about age 2, and * marks a second dose given later, at age 4-6; oral rotavirus is not an injection. The most-cited US total, "up to 24 immunizations by age 2," counts doses, not needles (National Academies / IOM, 2013).

Official schedules, current as of 2026: United States (CDC), United Kingdom (NHS / UKHSA), France (Santé publique France), Germany (RKI / STIKO), Denmark (Sundhedsstyrelsen), Sweden (Folkhälsomyndigheten), Australia (Dept. of Health), Japan (JIHS/NIID), and South Korea (KDCA). Antigen figures: Offit et al., Pediatrics 2002.

Shots at the 2-month visit

The number of injections a baby receives at the standard two-month appointment. Oral rotavirus is given on top of these but is not a shot.

🇺🇸United States
up to 5
injections

Whooping cough, Hib, pneumococcal, polio, and hepatitis B - as separate shots, plus oral rotavirus.

🇫🇷France
2
injections

A single 6-in-1 combination shot plus pneumococcal, plus oral rotavirus.

🇩🇰Denmark
0
injections

Denmark gives nothing at 2 months. Its schedule starts at 3 months, then 2 injections.

The US "up to 5" is the standard two-month visit and the source of the IOM's "up to five injections in a single visit." Combination shots lower the needle count where they are used. Schedules: CDC, Santé publique France, Danish Health Authority.

What the US gives that most of Europe does not

The gap is specific, not general. The United States has long given three things almost none of these countries give every child: a Hepatitis B shot at birth, a universal Hepatitis A series, and a flu shot every year from infancy. Denmark goes further the other way, leaving out Hepatitis B, rotavirus, and chickenpox from its universal program entirely.

The reasons are epidemiological and economic, not doubts about safety. The US birth-dose Hepatitis B policy was a safety net for cases where a mother's infection was missed; most of Europe relies instead on universal prenatal screening and vaccinates only the newborns actually at risk. Hepatitis A is common enough in parts of the US to justify universal childhood coverage; in low-incidence Europe it is targeted to travelers and risk groups.

The pattern is not only European. Japan uses a measles-rubella shot rather than MMR and leaves mumps off the routine schedule entirely, while adding a tuberculosis vaccine and a Japanese encephalitis vaccine the US never gives. Every country tailors the list to its own disease burden.

The direction is not one-way. France and Germany vaccinate every infant against meningococcal B, which the US does not. And in late 2025 and early 2026 the US moved toward the leaner European model on two vaccines: a federal advisory committee voted to roll back the universal Hepatitis B birth dose to a targeted approach, and the CDC curtailed universal childhood Hepatitis A. Both changes are recent and contested.

The "too many, too soon" question

The most common worry is that children now get too many shots too young, more than a small immune system can handle. The shot count has indeed risen. The immunologic load has fallen sharply in the same period, and this is where the numbers cut against the intuition.

A vaccine challenges the immune system with antigens, the molecular pieces it learns to recognize. The 1980 schedule contained about 3,041 of them. By 2000, after the smallpox vaccine was dropped and the old whole-cell pertussis vaccine was replaced with a purified version, the entire schedule contained roughly 123 to 126, a drop of about 96 percent, even as the number of injections grew. A child today gets more needles but a fraction of the immunologic exposure a child got forty years earlier.

The scale also matters. A single common cold exposes a child to roughly 10 antigens; a case of strep throat, 25 to 50. The full vaccine schedule is small next to what a child's immune system handles every day from ordinary life. The researchers who ran the original analysis estimated an infant could in theory respond to thousands of vaccines at once. No study has found that the number or timing of recommended vaccines overwhelms or weakens a child's immune system.

What a delayed schedule actually means

A delayed or alternative schedule spreads doses across more visits, pushes them to older ages, separates combination shots, or drops some vaccines. The best-known version, promoted by the pediatrician Robert Sears, lets parents space out or withhold doses.

The evidence for a benefit is thin. A study following children into grade school found that on-time infants did as well or better than delayed ones on later neuropsychological tests. The American Academy of Pediatrics states there is no medical reason to delay or space out the recommended immunizations.

The measured costs are real. Delaying a vaccine leaves a child unprotected during the months of highest vulnerability. Children who were behind on pertussis shots were many times more likely to catch the disease. And giving the measles vaccine later than the recommended window raises, rather than lowers, the small risk of a fever-related seizure in the days after the shot.

The honest nuance is worth keeping. A large 2021 cohort found the elevated pertussis risk sits in undervaccination itself, not in a modest delay: children who ultimately received the full number of doses were not at higher risk from a short slip in timing. The problem is doses missed, not a schedule shifted by a few weeks and then completed.

Mandatory or voluntary, at home and abroad

Countries are split. France mandates 11 infant vaccines and enforces it for daycare and school. Germany mandates measles. Australia ties family and childcare payments to being fully immunized, its "No Jab, No Pay" policy. The Nordic countries mandate nothing at all: their programs are voluntary and free. And yet Denmark, Sweden, and Norway sustain childhood coverage in the mid-90s percent. Voluntary does not mean low uptake when trust in the system is high.

The US runs the experiment at the state level. Every state requires certain vaccines for school and allows medical exemptions. Forty-five states plus Washington, D.C., also allow religious exemptions, and sixteen allow a personal or philosophical exemption. Only four states now permit essentially medical exemptions alone: California, Connecticut, Maine, and New York, each having tightened its law after an outbreak.

Where exemptions cluster, disease follows. Communities with low coverage drove the 2019 measles resurgence, the largest in the US since 1992, and a Texas county with low vaccination anchored a large 2025 outbreak. Studies going back two decades tie easier exemptions to higher rates of measles and pertussis. National kindergarten measles coverage has slipped to about 92.7 percent, below the roughly 95 percent needed to stop the disease from spreading, as the exemption rate hit a record.

Do the healthiest countries vaccinate less?

The intuition that the longest-living nations must have pared their schedules down does not survive contact with the data. Life expectancy at birth is 84.0 years in Japan, 83.4 in South Korea, and 83.1 in Australia, against 78.4 in the United States. All three outlive the US, and all three vaccinate extensively, with coverage between 93 and 99 percent.

Australia is the clean test. It is roughly five years healthier than the US, gives the hepatitis B birth dose, universal rotavirus, meningococcal ACWY, universal childhood flu, and MMR with mumps, and it is the only country here that legally and financially mandates vaccination. Where these countries are genuinely leaner than the US, it reflects a specific product or antigen choice, Japan dropping routine mumps or Australia's two-plus-one pneumococcal schedule, not a decision to give fewer vaccines overall. The leanness of a schedule is not what drives a nation's health.

Where the genuine debate is

Not every question is settled. Three specific components are argued by mainstream experts, on strategy and cost rather than safety.

The Hepatitis B birth dose

Should every newborn get a Hepatitis B shot within a day of birth, as a safety net, or only the infants of infected mothers identified by prenatal screening? Most of Europe takes the targeted approach. The US used the universal birth dose for three decades, then voted in December 2025 to move toward the European model, over the objection of the American Academy of Pediatrics. A real disagreement about how much of a safety margin is worth keeping.

Universal chickenpox

The US has vaccinated every child against chickenpox since 1995. Many European countries declined, partly over a theory that removing the circulating virus might raise adult shingles. The UK reversed course in 2023 and added it in 2026 after new modelling and two decades of US data found no clear rise in shingles and a cost-effective program. Evidence that genuinely shifted a policy.

Rotavirus and Hepatitis A, on cost

Rotavirus is the textbook case of a price-driven decision: the UK adopted it only once it could buy the vaccine below a cost-effectiveness threshold. Hepatitis A tracks local disease burden, universal in the higher-incidence US and targeted in lower-incidence Europe. These are health-economics judgments, and they change as prices and disease patterns change.

What the comparison supports, and what it does not

The differences between the US and other schedules are real, and they are worth understanding. Countries make different, defensible choices about which vaccines to give and when, driven by their own disease burden, health systems, and prices. On a handful of vaccines the US has recently decided its longstanding approach was more than it needed, and moved toward the leaner one.

What the comparison does not support is the further step of delaying or skipping the recommended vaccines for a given child. The concern that drives it, that too many shots overwhelm a young immune system, runs against the numbers: the schedule carries a small fraction of the immunologic load it did a generation ago. Spacing doses out has shown no benefit and a measured cost, and the countries with leaner schedules are not delaying out of caution, they are making different program-level choices and still reaching very high coverage. The question worth asking is which specific vaccines a country should give and when. That debate is live, and the evidence, not the intuition, should settle each piece of it.

Sources

  1. CDC, Child and Adolescent Immunization Schedule
  2. National Academies (IOM), The Childhood Immunization Schedule and Safety (2013)
  3. Offit et al., "Do multiple vaccines overwhelm or weaken the infant's immune system?" Pediatrics 2002
  4. CDC, Multiple Vaccines and the Immune System
  5. American Academy of Pediatrics - no reason to delay or space out immunizations
  6. ECDC Vaccine Scheduler (national childhood schedules, EU/EEA)
  7. UK NHS vaccination schedule
  8. France, Loi n° 2017-1836 (11 mandatory infant vaccines)
  9. Germany STIKO recommendations (measles mandate; MenB; varicella)
  10. Danish Health Authority / Statens Serum Institut - childhood immunisation programme
  11. Public Health Agency of Sweden - vaccination programmes
  12. Australia National Immunisation Program (Dept. of Health via Healthdirect)
  13. Japan JIHS/NIID immunization schedule
  14. South Korea KDCA National Immunization Program
  15. Smith & Woods, on-time vs delayed vaccination and neuropsychological outcomes, Pediatrics 2010
  16. Glanz et al., undervaccination and pertussis risk, JAMA Pediatrics 2013
  17. Rowhani-Rahbar et al., MMR timing and febrile seizures, JAMA Pediatrics 2013
  18. Rane et al., vaccination timing and pertussis, JAMA Network Open 2021
  19. NCSL, states with religious and philosophical exemptions
  20. CDC MMWR, kindergarten vaccination coverage and exemptions, 2023-24
  21. UK JCVI, varicella (chickenpox) recommendation and MMRV program
  22. AAP News, response to the December 2025 Hepatitis B birth-dose decision
  23. World Bank, life expectancy at birth (Japan, Korea, Australia, US)